- Q1 2024 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024€40.05 (-0.76%)Earnings
- Q4 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptFeb 22, 2024€44.6Earnings
- Rhythm Pharmaceuticals Inc To Discuss On MC4R Pathway Programs Call TranscriptDec 06, 2023
- Q3 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2023€24 (-3.23%)Earnings
- Rhythm Pharmaceuticals Inc To Discuss Data Presentations Call TranscriptOct 18, 2023
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Rhythm Pharmaceuticals Inc at Canaccord Genuity Growth Conference TranscriptAug 09, 2023
- Q2 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptAug 01, 2023€15.9Earnings
- Rhythm Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Rhythm Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2023€17.9 (+1.13%)Earnings
- Rhythm Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Q4 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2023€22.4Earnings
- Rhythm Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Q3 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022€22.4 (-1.75%)Earnings
- Rhythm Pharmaceuticals Inc To Discuss Hypothalamic Obesity Call TranscriptNov 02, 2022
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptAug 02, 2022€11.8 (-0.84%)Earnings
- Rhythm Pharmaceuticals Inc To Discuss Hypothalamic Obesity Call TranscriptJul 12, 2022
- Rhythm Pharmaceuticals Inc To Discuss The FDA Approval Of IMCIVREE Call TranscriptJun 16, 2022
- Rhythm Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 08, 2022
- Rhythm Pharmaceuticals Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2022€5.65 (+0.89%)Earnings
- Q4 2021 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2022€6.65 (+1.53%)Earnings
- Rhythm Pharmaceuticals Inc To Host Virtual Bardet-Biedl Syndrome (BBS) Event Call TranscriptFeb 16, 2022
- Q3 2021 Rhythm Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2021€10.1 (-0.98%)Earnings
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Rhythm Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2021€13.8 (-4.83%)Earnings
- Rhythm Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 09, 2021
- Rhythm Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Rhythm Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptJan 26, 2021
- Rhythm Pharmaceuticals Inc Bardet-Biedl and Alstrom Syndromes Phase 3 Data Corporate Call TranscriptDec 22, 2020
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptNov 27, 2020
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Rhythm Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 17, 2020
- Rhythm Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- Rhythm Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptSep 25, 2019
- Rhythm Pharmaceuticals Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptAug 07, 2019
- Rhythm Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptMar 28, 2019
Rhythm Pharmaceuticals Inc To Discuss On MC4R Pathway Programs Call Transcript
Thank you, everybody, for coming. I'm Dave Connolly here at Rhythm Pharmaceuticals, and thanks for coming to our R&D event this morning. We issued a press release today that provides details on today's update on MC4R pathway programs, and it is available on our website.
Our forward-looking statements disclosure slide here on slide 2, please read them. And with that in mind, I'll remind you, this event contains remarks concerning future expectations, plans, prospects which constitute forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those discussed in our most recent annual or quarterly reports on file with the SEC. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent dates. And we specifically disclaim any obligation to update such statements.
As a brief overview of today's event, I'll briefly introduce each of today's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)